NYSEAMERICAN:YCBD cbdMD (YCBD) Stock Price, News & Analysis $0.24 -0.02 (-7.69%) Closing price 03/28/2025 04:10 PM EasternExtended Trading$0.25 +0.01 (+5.42%) As of 03/28/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock About cbdMD Stock (NYSEAMERICAN:YCBD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get cbdMD alerts:Sign Up Key Stats Today's Range$0.24▼$0.2650-Day Range N/A52-Week Range$0.23▼$1.25Volume190,853 shsAverage Volume607,096 shsMarket Capitalization$1.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewcbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.Read More… Remove Ads cbdMD Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreYCBD MarketRank™: cbdMD scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for cbdMD. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatiocbdMD has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about cbdMD's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted8.02% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 10.70%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldcbdMD does not currently pay a dividend.Dividend GrowthcbdMD does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.02% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 10.70%, indicating that investor sentiment is improving significantly. News and Social Media0.6 / 5News SentimentN/A Search Interest6 people have searched for YCBD on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, cbdMD insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.95% of the stock of cbdMD is held by insiders.Percentage Held by InstitutionsOnly 7.18% of the stock of cbdMD is held by institutions.Read more about cbdMD's insider trading history. Receive YCBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter. Email Address YCBD Stock News HeadlinescbdMD, Inc. (AMEX:YCBD) Q1 2025 Earnings Call TranscriptFebruary 15, 2025 | insidermonkey.comcbdMD Achieves Profitability, Highlights Growth in Earnings CallFebruary 14, 2025 | tipranks.comTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. March 30, 2025 | Paradigm Press (Ad)cbdMD targets growth with new product launches and improved profitability in Q1 2025February 14, 2025 | seekingalpha.comcbdMD (YCBD) Gets a Buy from Maxim GroupFebruary 14, 2025 | markets.businessinsider.comcbdMD, Inc. (YCBD) Q1 2025 Earnings Call TranscriptFebruary 14, 2025 | seekingalpha.comcbdMD discloses NYSE listing compliance noticeJanuary 4, 2025 | msn.comcbdMD Expands Board with CEO T. Ronan KennedyDecember 23, 2024 | tipranks.comSee More Headlines YCBD Stock Analysis - Frequently Asked Questions How have YCBD shares performed this year? cbdMD's stock was trading at $0.3279 on January 1st, 2025. Since then, YCBD shares have decreased by 26.8% and is now trading at $0.24. View the best growth stocks for 2025 here. How were cbdMD's earnings last quarter? cbdMD, Inc. (NYSEAMERICAN:YCBD) issued its quarterly earnings data on Thursday, December, 16th. The company reported ($3.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.03) by $1.13. The business earned $9.79 million during the quarter. cbdMD had a negative net margin of 13.67% and a negative trailing twelve-month return on equity of 109.27%. When did cbdMD's stock split? cbdMD's stock reverse split on the morning of Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. Who are cbdMD's major shareholders? cbdMD's top institutional investors include Concourse Financial Group Securities Inc.. View institutional ownership trends. How do I buy shares of cbdMD? Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of cbdMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that cbdMD investors own include Village Farms International (VFF), Tilray (TLRY), NVIDIA (NVDA), Roku (ROKU), Organigram (OGI), Bristol-Myers Squibb (BMY) and Bionano Genomics (BNGO). Company Calendar Last Earnings12/16/2021Today3/30/2025Next Earnings (Estimated)5/13/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Toilet preparations Sub-IndustryConsumer Goods Current SymbolNYSEAMERICAN:YCBD CIK1644903 Webwww.cbdmd.com Phone(704) 445-3060FaxN/AEmployees90Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,700,000.00 Net Margins-13.67% Pretax Margin-13.67% Return on Equity-109.27% Return on Assets-21.28% Debt Debt-to-Equity RatioN/A Current Ratio0.69 Quick Ratio0.46 Sales & Book Value Annual Sales$19.48 million Price / Sales0.08 Cash FlowN/A Price / Cash FlowN/A Book Value$0.28 per share Price / Book0.86Miscellaneous Outstanding Shares6,260,000Free Float6,204,000Market Cap$1.50 million OptionableNot Optionable Beta2.04 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSEAMERICAN:YCBD) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding cbdMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share cbdMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.